Virus infection is one of the most serious public health problems facing the world today. Between now and then, several antiviral medicines have been tested to determine their effectiveness as prospective COVID-19 treatments. The rise of viral resistance, as well as the adverse effects associated with antiviral medications, are posing further hurdles, resulting in a decrease in their efficiency as antiviral treatments. This opens the possibility for developing an alternative antiviral material that is both safe and effective. When it comes to their potential to destroy a wide range of viruses, silver nanoparticles (Ag-NPs) laden fiber mats have emerged as a novel antiviral platform, according to the findings of the current study. In the past, Ag-NPs have been extensively examined for their antibacterial properties against a wide range of microorganisms. Their ability to combat hepatitis B and HIV has also been demonstrated to be encouraging, as has their ability to inhibit other viruses such as herpes simplex, monkey pox, and respiratory syncytial virus. Here, we tested the potential effect of silver nanoparticles as an alternative antiviral therapeutic based on their unique properties. When compared to imitative antivirals, elemental silver nanoparticles have the ability to attack many virus sites, reducing the likelihood of the virus developing resistance.
Our group has been developing silver nanoparticles loaded on toilet paper seat sheets, cellulose membranes, polymer dressings, and cotton textiles in response to the persistent issue. The new generation of fiber mats will be thoroughly described and tested against SARS-CoV-2 virus. SEM, EDS, TEM, and DLS will be utilized to identify the shape of our fibers and estimate the particle size of the embedded nanoparticles.